TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 71 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $434,759 | -7.9% | 11,529 | -7.4% | 0.00% | 0.0% |
Q2 2023 | $472,039 | +99.6% | 12,445 | +28.0% | 0.00% | – |
Q1 2023 | $236,512 | -16.3% | 9,725 | 0.0% | 0.00% | – |
Q4 2022 | $282,414 | -3.3% | 9,725 | 0.0% | 0.00% | – |
Q3 2022 | $292,000 | -19.8% | 9,725 | -3.4% | 0.00% | -100.0% |
Q2 2022 | $364,000 | -16.3% | 10,066 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $435,000 | -19.7% | 10,066 | -7.0% | 0.00% | 0.0% |
Q4 2021 | $542,000 | -21.3% | 10,823 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $689,000 | -0.3% | 10,823 | +12.7% | 0.00% | 0.0% |
Q2 2021 | $691,000 | -5.0% | 9,600 | -2.7% | 0.00% | 0.0% |
Q1 2021 | $727,000 | +0.4% | 9,863 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $724,000 | -21.6% | 9,863 | +20.4% | 0.00% | -50.0% |
Q3 2017 | $923,000 | +0.5% | 8,192 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $918,000 | -20.7% | 8,192 | -17.5% | 0.00% | 0.0% |
Q1 2017 | $1,157,000 | +15.8% | 9,925 | +4.6% | 0.00% | 0.0% |
Q4 2016 | $999,000 | – | 9,487 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ISZO CAPITAL LP | 1,104,068 | $104,886,000 | 77.66% |
Greywolf Capital Management LP | 472,135 | $46,694,000 | 10.17% |
Consonance Capital Management LP | 263,732 | $26,083,000 | 4.28% |
Moab Capital Partners | 83,132 | $8,222,000 | 3.77% |
Raging Capital Management, LLC | 190,151 | $18,806,000 | 3.45% |
Valentine Capital Asset Management, Inc. | 145,053 | $14,346,000 | 3.07% |
Assured Investment Management LLC | 1,353,342 | $133,846,000 | 1.21% |
Ativo Capital Management LLC | 22,828 | $2,258,000 | 0.99% |
Perceptive Advisors | 56,602 | $5,598,000 | 0.67% |
Jaffetilchin Investment Partners, LLC | 7,721 | $764,000 | 0.38% |